Cyclo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Cyclo Therapeutics

15/08/2023 14:18

* Cyclo Therapeutics Inc  CYTH.OQ  reported a quarterly
adjusted
loss of 33 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 44 cents
per share.
    * Revenue fell 78.4% to $117.00 thousand from a year ago;
analysts
expected $396.00 thousand. 
    * Cyclo Therapeutics Inc's reported EPS for the quarter was
a loss
of 33 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cyclo Therapeutics Inc shares had fallen by 8.2% this
quarter and gained 2.8% so far this year.
    * The company reported a quarterly loss of $4.64 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 01:18 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.44          -0.33          Beat
 Mar. 31 2023      -0.42          -0.46          Missed
 Dec. 31 2022      -0.25          -0.59          Missed
 Sep. 30 2022      -0.53          -0.50          Beat